Systemic Angiotensinogen Concentrations Are Independently Associated With Left Ventricular Diastolic Function in a

Aletta M E Millen1, Angela J Woodiwiss1, Monica Gomes1

  • 1Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Insights

Systemic angiotensinogen (AGT) concentrations are linked to left ventricular (LV) diastolic dysfunction in Black Africans. This suggests the renin-angiotensin-aldosterone system (RAAS) may influence heart function in this population.

Area of Science:

  • Cardiology
  • Renal Physiology
  • Population Health

Background:

  • Left ventricular (LV) diastolic dysfunction is a key feature of heart failure with preserved ejection fraction.
  • The renin-angiotensin-aldosterone system (RAAS) is known to impair LV diastolic function.
  • The specific role of systemic angiotensinogen (AGT) in this process remains unclear.

Purpose of the Study:

  • To investigate the association between systemic AGT concentrations and LV diastolic function.
  • To explore the potential contribution of systemic AGT to diastolic dysfunction in an African population.

Main Methods:

  • LV diastolic function assessed using myocardial tissue Doppler imaging (average e') and mitral inflow velocity (E/e') in 445 Black African participants.
  • Multivariate regression models adjusted for multiple demographic, clinical, and lifestyle factors.

Main Results:

  • Serum AGT concentrations were independently associated with E/e' (P=0.04), a marker of diastolic dysfunction.
  • No significant association was found between AGT and average e', nor between plasma renin and diastolic function markers.
  • The association between AGT and E/e' persisted after adjusting for blood pressure and other confounders.

Conclusions:

  • Circulating AGT levels are associated with LV diastolic function in a Black African population, independent of blood pressure.
  • Systemic AGT, via the RAAS, may play a significant role in the development of LV diastolic dysfunction in this demographic.
  • Further research is warranted to elucidate the precise mechanisms.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
641
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
635
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.6K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
630